查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1481283

退伍軍人症桿菌測試市場 - 按測試類型、應用、最終用途 - 全球預測，2024 年 - 2032 年

Legionella Testing Market - By Test Type, Application, End-use - Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 201 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在監管機構執行日益嚴格的水檢測法規的推動下，全球 退伍軍人症桿菌檢測市場規模在 2024 年至 2032 年間將實現 8.6% 的複合年成長率。隨著公眾健康和安全問題的顯著增加，世界各地的當局正在對水系統中的 退伍軍人症桿菌檢測實施嚴格的標準。

例如，2024 年，美國總務管理局 (GSA) 宣布將對眾多聯邦建築進行全面的水質測試，以優先考慮居住者和遊客的健康和安全。這種積極主動的方法有助於建築經理保持健康的工作環境。 GSA 設施管理助理專員 Courtney Springer 闡述了他們的水質檢測和修復策略。確保水系統的適當維護和測試對於最大限度地減少重金屬和有利於細菌（包括 退伍軍人症桿菌）生長的條件的存在至關重要。這項工作對於大型建築（例如許多 GSA 設施）以及具有裝飾性噴泉或冷卻水塔等獨特功能的建築尤其重要。

這導致對能夠準確識別細菌的測試服務和解決方案的需求激增。隨著監管審查的加強， 退伍軍人症桿菌檢測市場持續成長，反映出人們為確保水質和降低退伍軍人病爆發風險而做出的共同努力。

整個 退伍軍人症桿菌測試市場根據測試類型、應用、最終用戶和地區進行分類。

從 2024 年到 2032 年，尿抗原檢測領域將經歷重大發展。尿液抗原檢測因其方便和高效而成為首選診斷工具，推動了對檢測服務和解決方案的需求。隨著醫療保健提供者越來越依賴這種方法進行及時診斷和治療， 退伍軍人症桿菌檢測市場不斷擴大，以滿足對有效檢測解決方案不斷成長的需求。

從2024 年到2032 年，體外診斷測試領域的 退伍軍人症桿菌檢測市場佔有率將實現顯著的複合年成長率。 。體外診斷測試為醫療保健專業人員提供及時、可靠的結果，促進及時治療和遏制工作。隨著早期檢測的重要性不斷增加，對體外診斷測試解決方案的需求也在增加，從而推動了 退伍軍人症桿菌測試市場的擴張，以滿足不斷變化的醫療保健需求。

歐洲 退伍軍人症桿菌檢測市場從2024 年到2032 年將呈現出值得稱讚的複合年成長率。協議，包括醫療機構、商業建築和工業場所。

對預防措施和早期檢測的日益重視，刺激了整個地區對 退伍軍人症桿菌檢測服務和產品的需求，推動了 退伍軍人症桿菌檢測市場的成長。例如，2023年8月，波蘭東南部城市熱舒夫的供水中檢測到 退伍軍人症桿菌後，波蘭啟動了一項調查。該國反情報機構 ABW 調查了故意污染的可能性，作為預防措施，熱舒夫對其供水系統採取了消毒措施。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 肺炎和 退伍軍人症桿菌相關疾病的發生率上升
      • 退伍軍人症桿菌檢測的快速進展
      • 定期水質檢測的嚴格規定
    • 產業陷阱與挑戰
      • 與測試程序相關的高成本
      • 診斷測試的敏感度問題
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場估計與預測：按測試類型，2018 年 - 2032 年

  • 主要趨勢
  • 培養方法
  • 尿抗原檢測（UAT）
  • 血清學
  • 直接螢光抗體測試（DFA）
  • 聚合酶鍊式反應 (PCR) 檢測
  • 其他測試類型

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

  • 主要趨勢
  • 水質檢測
    • 微生物培養
    • DFA染色
    • 聚合酶鍊式反應
  • 體外診斷 (IVD) 測試
    • 血液培養和痰液檢查
    • 尿抗原測試
    • DFA染色
    • 聚合酶鍊式反應
  • 其他應用

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 水處理廠
  • 診斷實驗室
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Abbott Laboratories
  • Becton, Dickinson & Company
  • Biomerieux
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • IDEXX Laboratories Inc
  • Merck KGaA
  • Pro-lab Diagnostics Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
簡介目錄
Product Code: 8361

Global Legionella Testing Market size will witness 8.6% CAGR between 2024 and 2032, driven by increasingly stringent water testing regulations enforced by regulatory bodies. With a significant rise in public health and safety concerns, authorities worldwide are imposing rigorous standards for Legionella detection in water systems.

For instance, in 2024, the General Services Administration (GSA) announced that it is conducting comprehensive water testing across numerous federal buildings to prioritize the health and safety of occupants and visitors. This proactive approach aids building managers in maintaining a healthy work environment. Courtney Springer, Assistant Commissioner for Facilities Management at GSA, shed light on their water testing and remediation strategies. Ensuring proper maintenance and testing of water systems is crucial to minimize the presence of heavy metals and conditions conducive to bacterial growth, including Legionella. This effort is particularly vital for large buildings, such as many GSA facilities, and those with unique features like decorative fountains or cooling towers.

This has led to a surge in demand for testing services and solutions capable of accurately identifying the bacteria. As regulatory scrutiny intensifies, the market for Legionella testing continues to grow, reflecting a concerted effort to ensure water quality and mitigate the risk of Legionnaires' disease outbreaks.

The overall Legionella Testing Market is classified based on the test type, application, end-user, and region.

The urinary antigen test segment will undergo significant development from 2024 to 2032. This approach offers a rapid and reliable means of detecting Legionella bacteria, particularly in cases of Legionnaires' disease. Urinary antigen testing has emerged as a preferred diagnostic tool for its convenience and efficiency, driving demand for testing services and solutions. As healthcare providers increasingly rely on this method for timely diagnosis and treatment, the Legionella Testing Market continues to expand to meet the growing need for effective testing solutions.

The legionella testing market share from the in vitro diagnostics testing segment will register a noteworthy CAGR from 2024 to 2032. These advanced diagnostic techniques offer accurate and efficient detection of Legionella bacteria crucial in preventing Legionnaires' disease outbreaks. In vitro diagnostics testing provides healthcare professionals with timely and reliable results, facilitating prompt treatment and containment efforts. As the importance of early detection grows, so does the demand for in vitro diagnostics testing solutions, fueling the expansion of the Legionella Testing Market to meet evolving healthcare needs.

Europe legionella testing market will showcase a commendable CAGR from 2024 to 2032. With a focus on public health and safety, European countries are increasingly implementing comprehensive testing protocols for water systems in various settings, including healthcare facilities, commercial buildings, and industrial sites.

This increased emphasis on preventive measures and early detection is fueling the demand for Legionella testing services and products across the region, driving growth in the Legionella Testing Market. For instance, in August 2023, an investigation was initiated in Poland after Legionella bacteria was detected in the water supply of Rzeszow, a city in the southeastern region. The country's counterintelligence agency, ABW, looked into the possibility of intentional contamination, and as a precautionary step, Rzeszow undertook disinfection measures for its water supply system.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of pneumonia and legionella related illnesses
      • 3.2.1.2 Rapid advancements in legionella testing
      • 3.2.1.3 Stringent regulations for regular water testing
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High costs associated with testing procedures
      • 3.2.2.2 Issues in sensitivity of diagnostic tests
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Culture methods
  • 5.3 Urinary antigen test (UAT)
  • 5.4 Serology
  • 5.5 Direct fluorescent antibody test (DFA)
  • 5.6 Polymerase chain reaction (PCR) testing
  • 5.7 Other test types

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Water testing
    • 6.2.1 Microbial culture
    • 6.2.2 DFA stain
    • 6.2.3 PCR
  • 6.3 Invitro diagnostics (IVD) testing
    • 6.3.1 Blood culture and sputum tests
    • 6.3.2 Urinary antigen tests
    • 6.3.3 DFA stain
    • 6.3.4 PCR
  • 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospital and clinics
  • 7.3 Water treatment plants
  • 7.4 Diagnostic laboratories
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Mexico
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Becton, Dickinson & Company
  • 9.3 Biomerieux
  • 9.4 Bio-Rad Laboratories Inc.
  • 9.5 Danaher Corporation
  • 9.6 IDEXX Laboratories Inc
  • 9.7 Merck KGaA
  • 9.8 Pro-lab Diagnostics Inc.
  • 9.9 QIAGEN N.V.
  • 9.10 Thermo Fisher Scientific Inc.